comparemela.com
  1. Home
  2. Live Updates
  3. Per Winter Lung Cancer Conference - Breaking News

Latest Breaking News On - Per winter lung cancer conference - Page 1 : comparemela.com

Neoadjuvant vs Perioperative Immune Checkpoint Blockade in Resectable NSCLC: How Do We Choose?

Survival outcomes following curative resection in resectable NSCLC have been poor and, until recently, the main tool oncologists had at their disposal was neoadjuvant or adjuvant chemotherapy.

United statesPerioperative pembrolizumab keytrudaSamuel rosnerNeoadjuvant nivolumab opdivoUniversity of maryland greenebaum comprehensive cancer centerAnnual winter lungMaryland greenebaum comprehensive cancer centerMeets primary endAnnual winter lung cancer conferencePer winter lung cancer conferenceLung cancer

Dr Leal on the Development of DLL3-Targeted Agents in SCLC

Ticiana Leal, MD, discusses the variety of DLL3-targeted agents in development for patients with small cell lung cancer and neuroendocrine tumors.

Department of hematologyEmory university school of medicineThoracic medical oncology programTiciana lealMedical oncologyEmory university schoolLung cancer conferencePer winter lung cancer conferenceDll3 targeted agentsPatients with small cell lung cancerNeuroendocrine tumors

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.